Effectiveness of different anticalcification treatments for stentless aortic bioprostheses

Thoracic and Cardiovascular Surgeon

Volumn 47, Issue 1, 1999, Pages 23-25

  Walther, Thomas ^a,b   Falk, V ^a   Diegeler, A ^a   Rauch, T ^a   Weigl, C ^a   Gummert, J ^a   Autschbach, R ^a   Mohr, F W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Anticalcification treatment; Experimental comparison; Stentless bioprostheses

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE; ARTICLE; BIOPROSTHESIS; CALCIFICATION; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STENT; SURGICAL TECHNIQUE;

EID: 0032897605     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013103     Document Type: Article

References (16)

1. Davila JC. Where is the ideal heart valve substitute? What has frustrated its realization? AnnThorac Surg. 1989;48:S20-3.
2. Burman SO. Heterologous heart valves: past, present, and future. Ann Thor Surg. 1989;48:S75-6.
3. Jamieson WR. Modern cardiac valve devices - bioprostheses and mechanical prostheses: state of the art. J Card Surg. 1993;8 : 89-98
4. Walther T, Falk V, Rutschbach R, Scheidt A, Baryalei M, Schindewolf K, Dalichau H, Mohr FW. Hemodynamic assessment of the stentless Toronto SPV™ bioprosthesis by echocardiography. J Heart Valve Dis. 1994;3 : 657-65
5. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mat Res. 1994;28 : 655-66.
6. Schoen FJ, Levy RJ. Pathology of substitute heart valves: new concepts and developments. J Card Surg. 1994;9(Suppl.): 222-7.
7. Turina J, Hess OM, Turina M, Krayenbuehl HP. Cardiac bioprostheses in the 1990s. Circulation. 1993;88 : 775-81.
8. Levy RJ. Clutaraldehyde and the calcification mechanism of bioprosthetic heart valves (Editorial). J Heart Valve Dis. 1994; 3 : 101-4.
9. Gong G, Ling Z, Seifter E, Factor SM, Frater RWM. Aldehyde tanning: the villain in bioprosthetic calcification. Eur J Cardio-thor Surg. 1991;5 : 288-93.
10. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation. 1994; 90 : 323-9
11. Gott JP, Pan-Chi H, Dorsey LMA, et al. Calcification of porcine valves: a successful new method of antimineralization. Ann Thorac Surg. 1992;53 : 207-16.
12. Abolhoda A, Yu S, Oyarzun R, McCormick JR, Bogden JD, Gabba S. Calcification of bovine pericardium: glutaraldehyde versus No-React biomodification. Ann Thorac Surg. 1996;62 : 169-74.
13. Vyavahare N, Hirsch D, Lerner E. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation. 1997;95 : 479-88.
14. Westaby S, Amarasena N, Ormerod O, Amarasena C, Pillai R. Aortic valve replacement with the freestyle stentless xenograft. Ann Thorac Surg. 1995; 60: S422-7.
15. Schoen FJ, Levy RJ, Hilbert SL, Bianco RW. Antimineralization treatments for bioprosthetic heart valves. Assessment of efficacy and safety. J Thorac Cardiovasc Surg. 1992;104 : 1285-8.
16. Walther T, Falk V, Autschbach R, et al. Comparison of different anticalcification treatments for stentless bioprostheses. Ann Thorac Surg. 1998;Suppl. Submitted.